Showing results (131-140 of 281) with videos related to
Sort By:
Pageof 29
Clinical Pharmacology and Therapeutics|October 21, 2011
Integration of diverse data sources for prediction of adverse drug eventsD R Abernethy, J P F Bai, K Burkhart, et al.Pharmacology|January 1, 1989
Oral 5-fluorouracil in psoriasis: pharmacokinetic-pharmacodynamic relationshipsD R Abernethy, J C Alper, M C Wiemann, et al.Clinical Pharmacokinetics|March 1, 1984
The influence of obesity on the pharmacokinetics of oral alprazolam and triazolamD R Abernethy, D J Greenblatt, M Divoll, et al.The American Journal of Medicine|November 14, 1983
Antipyretic analgesic drugs as models for studies of drug disposition in old ageD J Greenblatt, D R Abernethy, M Divoll, et al.Pharmacology|January 1, 1984
Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugationH R Ochs, D J Greenblatt, B Verburg-Ochs, et al.British Journal of Cancer|April 12, 2017
Tyrosine kinase-targeting drugs-associated heart failureN Gronich, I Lavi, O Barnett-Griness, et al.Journal of Clinical Psychopharmacology|April 1, 1983
Pharmacokinetic properties of benzodiazepine hypnoticsD J Greenblatt, D R Abernethy, M Divoll, et al.Clinical Pharmacokinetics|May 1, 1983
Clinical pharmacokinetics of the newer benzodiazepinesD J Greenblatt, M Divoll, D R Abernethy, et al.The American Journal of Cardiology|September 15, 1987
Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertensionD R Abernethy, J B Schwartz, J R Plachetka, et al.CPT: Pharmacometrics & Systems Pharmacology|September 18, 2016
GPS for QSP: A Summary of the ACoP6 Symposium on Quantitative Systems Pharmacology and a Stage for Near-Term Efforts in the FieldC J Musante, D R Abernethy, S R Allerheiligen, et al.Pageof 29